DIFFERENT TYPES OF ANTIVIRAL THERAPY (AVT) IN PATIENTS WITH VIRAL HEPATITIS C‐ASSOCIATED DIFFUSE B‐CELL LYMPHOMA (HCV + DVCL).

Autor:	Lepkov, S., Tumian, G., Kolomeytsev, O., Lunina, S., Semenova, A., Tupicina, D., Kokosadze, N., Chernova, N., Ryabukhina, J., Zakharov, O., Borisovskay, S., Gavrilina, N., Manuilova, O., Savkina, K., Ivahenco, R., Kuprishina, N., Blagova, M., Podzarskiy, E., Ivanova, V., Trishina, V.
Předmět:	VIRAL hepatitis LYMPHOMAS DIFFUSE large B-cell lymphomas NON-Hodgkin's lymphoma MUCOSA-associated lymphoid tissue lymphoma
Zdroj:	Hematological Oncology; Jun2023 Supplement S2, Vol. 41, p822-822, 1p
Abstrakt:	The aim of our study was to investigate the effect of different modes of AVT on the feasibility and efficacy of antitumor treatment in pts with HCV + DBCL. DIFFERENT TYPES OF ANTIVIRAL THERAPY (AVT) IN PATIENTS WITH VIRAL HEPATITIS C-ASSOCIATED DIFFUSE B-CELL LYMPHOMA (HCV + DVCL) The etiopathogenetic link between HCV and B-cell non-Hodgkin's lymphoma is thought to be proven in marginal zone cell lymphoma. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text